ElMindA (Herzliya, Israel) received FDA clearance for its Brain Network Activity (BNA) Analysis System used to asses patients’ brain function. The system consists of an electroencephalograph (EEG) and software that does multi-layer processing of brain signals recorded during standardized cognitive tasks. The results are compared to recordings gathered from healthy people and those with known brain-related conditions in order to identify potential disorders in new patients.
Currently cleared for use on people between 14 and 24 years of age, the system relies on a database of over 7,000 previous EEG recordings, hopefully helping to spot concussions, ADHD, and other conditions common among older kids and young adults.
Here’s a short video of President Obama and Israel’s Prime Minister Benjamin Netanyahu checking out ElMindA’s technology last year.
Product page: The BNA Platform…
Press release: ElMindA Announces FDA Clearance of BNA™ Analysis System…